Caseware UK (AP4) 2024.0.164 2024.0.164 2024-12-312024-12-312024-12-31falsetrue2024-01-01false88false 12783713 2024-01-01 2024-12-31 12783713 2023-01-01 2023-12-31 12783713 2024-12-31 12783713 2023-12-31 12783713 2023-01-01 12783713 1 2024-01-01 2024-12-31 12783713 1 2023-01-01 2023-12-31 12783713 3 2024-01-01 2024-12-31 12783713 3 2023-01-01 2023-12-31 12783713 4 2024-01-01 2024-12-31 12783713 4 2023-01-01 2023-12-31 12783713 d:Director1 2024-01-01 2024-12-31 12783713 d:Director1 2024-12-31 12783713 d:Director2 2024-01-01 2024-12-31 12783713 d:Director3 2024-01-01 2024-12-31 12783713 d:Director3 2024-12-31 12783713 d:Director4 2024-01-01 2024-12-31 12783713 d:Director5 2024-01-01 2024-12-31 12783713 d:Director5 2024-12-31 12783713 d:Director6 2024-01-01 2024-12-31 12783713 d:Director6 2024-12-31 12783713 d:RegisteredOffice 2024-01-01 2024-12-31 12783713 e:FurnitureFittings 2024-01-01 2024-12-31 12783713 e:OfficeEquipment 2024-01-01 2024-12-31 12783713 e:ComputerEquipment 2024-01-01 2024-12-31 12783713 e:OtherPropertyPlantEquipment 2024-01-01 2024-12-31 12783713 e:CurrentFinancialInstruments 2024-12-31 12783713 e:CurrentFinancialInstruments 2023-12-31 12783713 e:Non-currentFinancialInstruments 2024-12-31 12783713 e:Non-currentFinancialInstruments 2023-12-31 12783713 e:CurrentFinancialInstruments e:WithinOneYear 2024-12-31 12783713 e:CurrentFinancialInstruments e:WithinOneYear 2023-12-31 12783713 e:Non-currentFinancialInstruments e:AfterOneYear 2024-12-31 12783713 e:Non-currentFinancialInstruments e:AfterOneYear 2023-12-31 12783713 e:ShareCapital 2024-12-31 12783713 e:ShareCapital 2023-12-31 12783713 e:ShareCapital 2023-01-01 12783713 e:SharePremium 2024-01-01 2024-12-31 12783713 e:SharePremium 2024-12-31 12783713 e:SharePremium 1 2024-01-01 2024-12-31 12783713 e:SharePremium 3 2024-01-01 2024-12-31 12783713 e:SharePremium 4 2024-01-01 2024-12-31 12783713 e:SharePremium 2023-12-31 12783713 e:SharePremium 2023-01-01 12783713 e:SharePremium 1 2023-01-01 2023-12-31 12783713 e:SharePremium 3 2023-01-01 2023-12-31 12783713 e:SharePremium 4 2023-01-01 2023-12-31 12783713 e:RetainedEarningsAccumulatedLosses 2024-01-01 2024-12-31 12783713 e:RetainedEarningsAccumulatedLosses 2024-12-31 12783713 e:RetainedEarningsAccumulatedLosses 1 2024-01-01 2024-12-31 12783713 e:RetainedEarningsAccumulatedLosses 3 2024-01-01 2024-12-31 12783713 e:RetainedEarningsAccumulatedLosses 4 2024-01-01 2024-12-31 12783713 e:RetainedEarningsAccumulatedLosses 2023-01-01 2023-12-31 12783713 e:RetainedEarningsAccumulatedLosses 2023-12-31 12783713 e:RetainedEarningsAccumulatedLosses 2023-01-01 12783713 e:RetainedEarningsAccumulatedLosses 1 2023-01-01 2023-12-31 12783713 e:RetainedEarningsAccumulatedLosses 3 2023-01-01 2023-12-31 12783713 e:RetainedEarningsAccumulatedLosses 4 2023-01-01 2023-12-31 12783713 d:OrdinaryShareClass1 2024-01-01 2024-12-31 12783713 d:OrdinaryShareClass1 2024-12-31 12783713 d:OrdinaryShareClass1 2023-12-31 12783713 d:OrdinaryShareClass2 2024-01-01 2024-12-31 12783713 d:OrdinaryShareClass2 2024-12-31 12783713 d:OrdinaryShareClass2 2023-12-31 12783713 d:OrdinaryShareClass3 2024-01-01 2024-12-31 12783713 d:OrdinaryShareClass3 2024-12-31 12783713 d:OrdinaryShareClass3 2023-12-31 12783713 d:FRS102 2024-01-01 2024-12-31 12783713 d:Audited 2024-01-01 2024-12-31 12783713 d:FullAccounts 2024-01-01 2024-12-31 12783713 d:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 12783713 e:Subsidiary1 2024-01-01 2024-12-31 12783713 e:Subsidiary1 1 2024-01-01 2024-12-31 12783713 e:Subsidiary2 2024-01-01 2024-12-31 12783713 e:Subsidiary2 1 2024-01-01 2024-12-31 12783713 e:Subsidiary3 2024-01-01 2024-12-31 12783713 e:Subsidiary3 1 2024-01-01 2024-12-31 12783713 e:Subsidiary4 2024-01-01 2024-12-31 12783713 e:Subsidiary4 1 2024-01-01 2024-12-31 12783713 e:Subsidiary5 2024-01-01 2024-12-31 12783713 e:Subsidiary5 1 2024-01-01 2024-12-31 12783713 e:Subsidiary6 2024-01-01 2024-12-31 12783713 e:Subsidiary6 1 2024-01-01 2024-12-31 12783713 e:Subsidiary7 2024-01-01 2024-12-31 12783713 e:Subsidiary7 1 2024-01-01 2024-12-31 12783713 e:Subsidiary8 2024-01-01 2024-12-31 12783713 e:Subsidiary8 1 2024-01-01 2024-12-31 12783713 e:Subsidiary9 2024-01-01 2024-12-31 12783713 e:Subsidiary9 1 2024-01-01 2024-12-31 12783713 e:Subsidiary10 2024-01-01 2024-12-31 12783713 e:Subsidiary10 1 2024-01-01 2024-12-31 12783713 e:Subsidiary11 2024-01-01 2024-12-31 12783713 e:Subsidiary11 1 2024-01-01 2024-12-31 12783713 e:Subsidiary12 2024-01-01 2024-12-31 12783713 e:Subsidiary12 1 2024-01-01 2024-12-31 12783713 e:Subsidiary13 2024-01-01 2024-12-31 12783713 e:Subsidiary13 1 2024-01-01 2024-12-31 12783713 e:Subsidiary14 2024-01-01 2024-12-31 12783713 e:Subsidiary14 1 2024-01-01 2024-12-31 12783713 e:Subsidiary15 2024-01-01 2024-12-31 12783713 e:Subsidiary15 1 2024-01-01 2024-12-31 12783713 e:Subsidiary16 2024-01-01 2024-12-31 12783713 e:Subsidiary16 1 2024-01-01 2024-12-31 12783713 e:Subsidiary17 2024-01-01 2024-12-31 12783713 e:Subsidiary17 1 2024-01-01 2024-12-31 12783713 e:Subsidiary18 2024-01-01 2024-12-31 12783713 e:Subsidiary18 1 2024-01-01 2024-12-31 12783713 e:Subsidiary19 2024-01-01 2024-12-31 12783713 e:Subsidiary19 1 2024-01-01 2024-12-31 12783713 e:Subsidiary20 2024-01-01 2024-12-31 12783713 e:Subsidiary20 1 2024-01-01 2024-12-31 12783713 e:Subsidiary21 2024-01-01 2024-12-31 12783713 e:Subsidiary21 1 2024-01-01 2024-12-31 12783713 e:Subsidiary22 2024-01-01 2024-12-31 12783713 e:Subsidiary22 1 2024-01-01 2024-12-31 12783713 e:Subsidiary23 2024-01-01 2024-12-31 12783713 e:Subsidiary23 1 2024-01-01 2024-12-31 12783713 e:Subsidiary24 2024-01-01 2024-12-31 12783713 e:Subsidiary24 1 2024-01-01 2024-12-31 12783713 e:Subsidiary25 2024-01-01 2024-12-31 12783713 e:Subsidiary25 1 2024-01-01 2024-12-31 12783713 e:Subsidiary26 2024-01-01 2024-12-31 12783713 e:Subsidiary26 1 2024-01-01 2024-12-31 12783713 e:Subsidiary27 2024-01-01 2024-12-31 12783713 e:Subsidiary27 1 2024-01-01 2024-12-31 12783713 e:Subsidiary28 2024-01-01 2024-12-31 12783713 e:Subsidiary28 1 2024-01-01 2024-12-31 12783713 e:Subsidiary29 2024-01-01 2024-12-31 12783713 e:Subsidiary29 1 2024-01-01 2024-12-31 12783713 e:Subsidiary30 2024-01-01 2024-12-31 12783713 e:Subsidiary30 1 2024-01-01 2024-12-31 12783713 d:Consolidated 2024-12-31 12783713 d:ConsolidatedGroupCompanyAccounts 2024-01-01 2024-12-31 12783713 2 2024-01-01 2024-12-31 12783713 6 2024-01-01 2024-12-31 12783713 e:ShareCapital 1 2024-01-01 2024-12-31 12783713 e:ShareCapital 3 2024-01-01 2024-12-31 12783713 e:ShareCapital 4 2024-01-01 2024-12-31 12783713 e:ShareCapital 1 2023-01-01 2023-12-31 12783713 e:ShareCapital 3 2023-01-01 2023-12-31 12783713 e:ShareCapital 4 2023-01-01 2023-12-31 12783713 f:PoundSterling 2024-01-01 2024-12-31 xbrli:shares iso4217:GBP xbrli:pure

Registered number: 12783713









EXAGEN GROUP LIMITED









ANNUAL REPORT AND FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2024

 
EXAGEN GROUP LIMITED
 
 
COMPANY INFORMATION


Directors
D Kemp 
E White 
J Littman (resigned 23 September 2024)
S Goss 
H Bond (resigned 20 December 2024)
C Gaydon (resigned 14 January 2025)




Registered number
12783713



Registered office
2nd Floor, Coachworks
9-10 Charlotte Mews

London

Greater London

W1T 4EF




Independent auditors
Wilder Coe Ltd
Chartered Accountants & Statutory Auditors

1st Floor, Sackville House

143 - 149 Fenchurch St

London

EC3M 6BL





 
EXAGEN GROUP LIMITED
 

CONTENTS



Page
Group Strategic Report
 
 
1 - 3
Directors' Report
 
 
4 - 5
Independent Auditors' Report
 
 
6 - 10
Consolidated Statement of Comprehensive Income
 
 
11
Consolidated Statement of Financial Position
 
 
12
Company Statement of Financial Position
 
 
13
Consolidated Statement of Changes in Equity
 
 
14
Company Statement of Changes in Equity
 
 
15
Consolidated Statement of Cash Flows
 
 
16
Consolidated Analysis of Net Debt
 
 
17
Notes to the Financial Statements
 
 
18 - 36


 
EXAGEN GROUP LIMITED
 
 
GROUP STRATEGIC REPORT
FOR THE YEAR ENDED 31ST DECEMBER 2024

Introduction
 
The Directors are pleased to present their strategic report on the Group's activities for the year ending 31 December 2024.

Principal Activities
 
The Group's primary activity is the development of renewable energy generation and energy storage projects. The Group aims to demonstrate, through construction and operations, that green energy can create a sustainable platform for investors, lenders and society. 
Exagen’s primary focus is the development of large-scale battery storage, utility-scale PV solar farms and onshore wind farms, co-located with grid-balancing battery storage technology. The Group originates and develops renewable energy projects, exploiting market opportunities in the disaggregated greenfield market in the UK. As projects move through the development phase, the Group’s aim is to incorporate construction and operation activities to complement its development activities.
Exagen is focused on making a significant contribution to achieving energy security and improved climate protection, by developing sustainable energy projects with enhanced biodiverse habitats. This has the potential to slowdown climate change and improve the lives of those communities near our projects. To achieve this, Exagen aims to be a key participant in the transition to a fossil-fuel free and low-carbon economy while never losing sight of the potential for positive social and environmental impact in the areas where our projects are located.

Business review
 
The financial statements reflect the Group's results and financial position for the year.
OEDP Acquisition
On 23rd September 2024, the Octopus Energy Development Partnership (OEDP) fund, previously a minority shareholder in the Group, acquired all Ordinary A shares in the Group through its' holding company OEDP UK HoldCo Ltd. As a result of this transaction, OEDP became the Group’s controlling party. This acquisition galvanises Exagen’s ambitious growth plans to contribute to the UK’s green energy transition and support the UK Government's objective to deliver clean power by 2030.
Operating Highlights
During the year, the Group continued to execute its strategy of progressing development projects through the consenting stages. As at 31 December 2024, Exagen held a portfolio of solar and battery storage projects with an aggregate capacity of c.2.4GW (2023: c.2.6GW) of which c.1.0GW had been submitted into local authorities for planning determination, with a further c0.4GW due to be submitted into planning in the 1H 2025.

Page 1

 
EXAGEN GROUP LIMITED
 

GROUP STRATEGIC REPORT (CONTINUED)
FOR THE YEAR ENDED 31ST DECEMBER 2024

Financial key performance indicators
 
The Group's key performance indicators are as follows:
The Group considers renewable energy Development Projects under Management, Work in Progress development assets and Net Profit to be its’ Key Performance Indicators. During the year the Group continued to develop a portfolio of renewable projects which meet its’ investment criteria. By the end of 2024 the Group had successfully retained a Development Projects under Management portfolio of 17 projects totalling c.2.4GW.
Work in Progress assets represent the Group’s deployment of development capital to progress its’ development pipeline and these assets are considered to reflect the Group’s medium-term investment.
The Group targets Net Profit in future periods earned through development fees, asset management fees and operational revenues from successfully developed renewable projects. The Net loss for 2024 reflects the administrative cost of the development platform in the period:
                                                                          
2024              2023
Development Projects under Management (GWs) c.2.4              c.2.6
Work in Progress                                                     £9,011,317              £5,172,418
Net Profit / (Loss)                                                      (£5,516,435)            (£4,968,947)

Page 2

 
EXAGEN GROUP LIMITED
 

GROUP STRATEGIC REPORT (CONTINUED)
FOR THE YEAR ENDED 31ST DECEMBER 2024

Principal risks and uncertainties
 
The Directors identify, assess, and manage risks associated with the Group's business objectives and strategy.
Operational Risk
The principal operational risk within the Group's project development phase is in securing land, grid and planning consent. Following a project’s planning consent, operational risk is more concentrated on procurement and construction, mitigated through careful contractor selection, project controls and insurances. Post construction, operational risk will be managed through remote site monitoring, reporting and management of component failure through O&M service level agreements. The Group manages its various operational risks through rigorous development project screening, risk registers, due diligence and governance.
Political and Regulatory Risk
The Group and its investments are subject to laws and regulations enacted by national and local governments and institutions. The sectors in which the Group's investments operate are subject to legal and regulatory controls, and the investee companies must comply with all applicable laws, regulations, and regulatory standards which, inter alia, require them to obtain and maintain certain authorisations, licenses and approvals for their operations.
Credit Risk
The credit risk on bank balances is limited due to the high credit ratings of the banking institutions used by the Group.
Liquidity Risk
The cash requirements of the Group are forecast by the Board annually in advance and reviewed monthly by management, enabling the Group's cash requirements to be anticipated. The cash forecast includes assumptions with respect to working capital, development spend and the timing of key milestones of development projects. Liquidity risk is managed by the following specific controls: 
• Preparation of budgets covering the medium term (to the end of the financial year); and
• Monitoring of current cash levels and of short-term cash requirements.
Future Developments
The Directors support the Group's strategy to continue growth of its development platform as well as continued deployment of development capital for its portfolio of projects and further opportunities.


This report was approved by the board on 18 September 2025 and signed on its behalf.



D Kemp
Director

Page 3

 
EXAGEN GROUP LIMITED
 
 
 
DIRECTORS' REPORT
FOR THE YEAR ENDED 31ST DECEMBER 2024

The directors present their report and the audited financial statements for the year ended 31 December 2024.

Directors' responsibilities statement

The directors are responsible for preparing the Group Strategic Report, the Directors' Report and the consolidated financial statements in accordance with applicable law and regulations.
 
Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice), including Financial Reporting Standard 102 ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland'. Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the Company and the Group and of the profit or loss of the Group for that period.

 In preparing these financial statements, the directors are required to:


select suitable accounting policies for the Group's financial statements and then apply them consistently;

make judgements and accounting estimates that are reasonable and prudent;

prepare the financial statements on the going concern basis unless it is inappropriate to presume that the Group will continue in business.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the Company's transactions and disclose with reasonable accuracy at any time the financial position of the Company and the Group and to enable them to ensure that the financial statements comply with the Companies Act 2006They are also responsible for safeguarding the assets of the Company and the Group and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

Principal activity

The principal activity of Exagen Group Limited ("the Company") is that of a holding company.
The principal activity of the Group is that of developing solar, onshore wind and battery storage projects.

Results and dividends

The loss for the year, after taxation, amounted to £5,516,435 (2023 - loss £4,968,947).

The Directors do not recommend a dividend for the year (2023: £Nil).

Page 4

 
EXAGEN GROUP LIMITED
 
 
 
DIRECTORS' REPORT (CONTINUED)
FOR THE YEAR ENDED 31ST DECEMBER 2024


Directors

The directors who served during the year were:

D Kemp (appointed 26 August 2021)
J Littman (appointed 7 June 2021, resigned 23 September 2024)
H Bond (appointed 14 March 2022, resigned 20 December 2024)
C Gaydon (appointed 7 July 2022, resigned 14 January 2025)

Post balance sheet events
After the reporting date, the following directors have been appointed:
S Goss (appointed 14 January 2025)
E White (appointed 14 January 2025)

Future developments

The future developments of the Group are disclosed in the Strategic Report.

Research and development activities

Exagen’s research and development activities to date have targeted automated identification of optimal land for utility scale battery energy storage, solar and wind farm renewable energy projects. This was achieved by using a system which comprises a group of interrelated and connected software applications to identify potential sites in relation to grid connection availability, by analysing and presenting a wide range of decision factors in near real time and provide both technical and commercial recommendations..

Disclosure of information to auditors

Each of the persons who are directors at the time when this Directors' Report is approved has confirmed that:
 
so far as the director is aware, there is no relevant audit information of which the Company and the Group's auditors are unaware, and

the director has taken all the steps that ought to have been taken as a director in order to be aware of any relevant audit information and to establish that the Company and the Group's auditors are aware of that information.

Auditors

The auditorsWilder Coe Ltdwill be proposed for reappointment in accordance with section 485 of the Companies Act 2006.

This report was approved by the board on 18 September 2025 and signed on its behalf.
 





D Kemp
Director

Page 5

 
EXAGEN GROUP LIMITED
 
 
 
INDEPENDENT AUDITORS' REPORT TO THE MEMBERS OF EXAGEN GROUP LIMITED
 

Opinion


We have audited the financial statements of Exagen Group Limited (the 'parent Company') and its subsidiaries (the 'Group') for the year ended 31st December 2024, which comprise the Consolidated Statement of Comprehensive Income, the Consolidated Statement of Financial Position, the Company Statement of Financial Position, the Consolidated Statement of Cash Flows, the Consolidated Statement of Changes in Equity, the Company Statement of Changes in Equity and the related notes, including a summary of significant accounting policiesThe financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland' (United Kingdom Generally Accepted Accounting Practice).


In our opinion the financial statements:


give a true and fair view of the state of the Group's and of the parent Company's affairs as at 31st December 2024 and of the Group's loss for the year then ended;
have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
have been prepared in accordance with the requirements of the Companies Act 2006.


Basis for opinion


We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditors' responsibilities for the audit of the financial statements section of our report. We are independent of the Group in accordance with the ethical requirements that are relevant to our audit of the financial statements in the United Kingdom, including the Financial Reporting Council's Ethical Standard and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.


Conclusions relating to going concern


In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.


Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the Group's or the parent Company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.


Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.


Page 6

 
EXAGEN GROUP LIMITED
 
 
 
INDEPENDENT AUDITORS' REPORT TO THE MEMBERS OF EXAGEN GROUP LIMITED (CONTINUED)


Other information


The other information comprises the information included in the Annual Report other than the financial statements and our Auditors' Report thereon. The directors are responsible for the other information contained within the Annual ReportOur opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.


We have nothing to report in this regard.


Opinion on other matters prescribed by the Companies Act 2006
 

In our opinion, based on the work undertaken in the course of the audit:


the information given in the Group Strategic Report and the Directors' Report for the financial year for which the financial statements are prepared is consistent with the financial statements; and
the Group Strategic Report and the Directors' Report have been prepared in accordance with applicable legal requirements.


Matters on which we are required to report by exception
 

In the light of the knowledge and understanding of the Group and the parent Company and its environment obtained in the course of the audit, we have not identified material misstatements in the Group Strategic Report or the Directors' Report.


We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion:


adequate accounting records have not been kept,, or returns adequate for our audit have not been received from branches not visited by us; or
the parent Company financial statements are not in agreement with the accounting records and returns; or
certain disclosures of directors' remuneration specified by law are not made; or
we have not received all the information and explanations we require for our audit.



Page 7

 
EXAGEN GROUP LIMITED
 
 
 
INDEPENDENT AUDITORS' REPORT TO THE MEMBERS OF EXAGEN GROUP LIMITED (CONTINUED)


Responsibilities of directors
 

As explained more fully in the Directors' Responsibilities Statement set out on page 4, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.


In preparing the financial statements, the directors are responsible for assessing the Group's and the parent Company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the Group or the parent Company or to cease operations, or have no realistic alternative but to do so.


Page 8

 
EXAGEN GROUP LIMITED
 
 
 
INDEPENDENT AUDITORS' REPORT TO THE MEMBERS OF EXAGEN GROUP LIMITED (CONTINUED)


Auditors' responsibilities for the audit of the financial statements
 

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an Auditors' Report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these Group financial statements.


Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:

Discussions with and enquiries of management and those charged with governance were held with a view to identifying those laws and regulations that could be expected to have a material impact on the financial statements. During the engagement team briefing, the outcomes of these discussions and enquiries were shared with the team, as well as consideration as to where and how fraud may occur in the entity.
The following laws and regulations were identified as being of significance to the entity:
Those laws and regulations considered to have a direct effect on the financial statements include UK financial reporting standards, company law, tax and distributable profits legislation. 
Those laws and regulations for which non-compliance may be fundamental to the operating aspects of the business and therefore may have a material effect on the financial statements.

Audit procedures undertaken in response to the potential risks relating to irregularities (which include fraud and non-compliance with laws and regulations) comprised of: enquiries of management and those charged with governance as to whether the entity complies with such laws and regulations; enquiries with the same concerning any actual or potential litigation or claims, inspection of relevant legal correspondence; testing the appropriateness of journal entries and the performance of analytical review to identify unexpected movements in account balances which may be indicative of fraud.
No instances of material non-compliance were identified. However, the likelihood of detecting irregularities, including fraud, is limited by the inherent difficulty in detecting irregularities, the effectiveness of the entity's controls and the nature, timing and extent of the audit procedures performed. Irregularities that result from fraud might be inherently more difficult to detect than irregularities that result from error. As explained above, there is an unavoidable risk that material misstatements may not be detected, even though the audit has been planned and performed in accordance with ISAs (UK).


A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council's website at: www.frc.org.uk/auditorsresponsibilities. This description forms part of our Auditors' Report.


Page 9

 
EXAGEN GROUP LIMITED
 
 
 
INDEPENDENT AUDITORS' REPORT TO THE MEMBERS OF EXAGEN GROUP LIMITED (CONTINUED)


Use of our report
 

This report is made solely to the Company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006Our audit work has been undertaken so that we might state to the Company's members those matters we are required to state to them in an Auditors' Report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the Company and the Company's members, as a body, for our audit work, for this report, or for the opinions we have formed.





Robert Bradman BA CA (Senior Statutory Auditor)
  
for and on behalf of
Wilder Coe Ltd
 
Chartered Accountants & Statutory Auditors
  
1st Floor, Sackville House
143 - 149 Fenchurch St
London
EC3M 6BL

25 September 2025
Page 10

 
EXAGEN GROUP LIMITED
 
 
CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME
FOR THE YEAR ENDED 31 DECEMBER 2024

2024
2023
Note
£
£

  

Turnover
  
-
-

Gross profit
  
-
-

Administrative expenses
  
(4,283,442)
(3,958,283)

Operating loss
 4 
(4,283,442)
(3,958,283)

Interest receivable and similar income
 8 
215,814
216,162

Interest payable and similar expenses
 9 
(1,594,715)
(1,369,119)

Loss before taxation
  
(5,662,343)
(5,111,240)

R&D tax credit
 10 
145,908
142,293

Loss for the financial year
  
(5,516,435)
(4,968,947)

  

(Loss) for the year attributable to:
  

Owners of the parent Company
  
(5,516,435)
(4,968,947)

The notes on pages 18 to 36 form part of these financial statements.

Page 11

 
EXAGEN GROUP LIMITED
REGISTERED NUMBER: 12783713

CONSOLIDATED STATEMENT OF FINANCIAL POSITION
AS AT 31 DECEMBER 2024

2024
2023
Note
£
£

Fixed assets
  

Intangible assets
 11 
627,616
806,428

Tangible assets
 12 
117,186
148,974

  
744,802
955,402

Current assets
  

Work in progress
 14 
9,011,317
5,172,418

Debtors due after more than 1 year
 15 
-
40,750

Debtors due within 1 year
 15 
476,100
296,553

Cash at bank and in hand
  
1,404,424
7,815,244

  
10,891,841
13,324,965

Creditors: amounts falling due within one year
 16 
(630,713)
(556,051)

Net current assets
  
 
 
10,261,128
 
 
12,768,914

Total assets less current liabilities
  
11,005,930
13,724,316

Creditors: amounts falling due after more than one year
 17 
(24,622,287)
(21,848,465)

Net liabilities
  
(13,616,357)
(8,124,149)


Capital and reserves
  

Allotted and called up share capital
 18 
1,143
1,161

Share premium account
 19 
1,398,585
1,374,340

Profit and loss account
 19 
(15,016,085)
(9,499,650)

Equity shareholders' deficit
  
(13,616,357)
(8,124,149)




The financial statements were approved and authorised for issue by the board and were signed on its behalf on 18 September 2025.





D Kemp
Director

The notes on pages 18 to 36 form part of these financial statements.

Page 12

 
EXAGEN GROUP LIMITED
REGISTERED NUMBER: 12783713

COMPANY STATEMENT OF FINANCIAL POSITION
AS AT 31 DECEMBER 2024

2024
2023
Note
£
£

Fixed assets
  

Investments
 13 
302
302

  
302
302

Current assets
  

Debtors: amounts falling due within one year
 15 
15,892,790
9,567,164

Cash at bank and in hand
  
1,013,202
7,102,505

  
16,905,992
16,669,669

Creditors: amounts falling due within one year
 16 
(9,755,565)
(9,766,062)

Net current assets
  
 
 
7,150,427
 
 
6,903,607

  

Creditors: amounts falling due after more than one year
  
(9,184,215)
(7,451,170)

  

Net liabilities
  
(2,033,486)
(547,261)


Capital and reserves
  

Allotted and called up share capital
 18 
1,143
1,161

Share premium
 19 
1,398,585
1,374,340

Profit and loss account brought forward
  
(1,922,762)
(1,061,060)

Loss for the year
  
(1,510,452)
(861,702)

Profit and loss account carried forward
  
(3,433,214)
(1,922,762)

Equity shareholder's deficit
  
(2,033,486)
(547,261)




The financial statements were approved and authorised for issue by the board and were signed on its behalf on 18 September 2025.





D Kemp
Director

The notes on pages 18 to 36 form part of these financial statements.

Page 13
 

 
EXAGEN GROUP LIMITED


 

CONSOLIDATED STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 DECEMBER 2024



Called up share capital
Share premium account
Profit and loss account
Total equity


£
£
£
£



At 1st January 2023
1,139
1,350,877
(4,530,703)
(3,178,687)



Comprehensive income for the year


Loss for the year
-
-
(4,968,947)
(4,968,947)


Premium on issues
-
23,463
-
23,463


Share issued during the year
30
-
-
30


Shares cancelled during the year
(9)
-
-
(9)





At 1st January 2024
1,160
1,374,340
(9,499,650)
(8,124,150)



Comprehensive income for the year


Loss for the year
-
-
(5,516,435)
(5,516,435)


Premium on issues
-
24,245
-
24,245


Share issued during the year
31
-
-
31


Shares cancelled during the year
(49)
-
-
(49)



At 31st December 2024
1,142
1,398,585
(15,016,085)
(13,616,358)



The notes on pages 18 to 36 form part of these financial statements.

Page 14

 

 
EXAGEN GROUP LIMITED


 

COMPANY STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 DECEMBER 2024



Called up share capital
Share premium account
Profit and loss account
Total equity


£
£
£
£



At 1st January 2023
1,139
1,350,877
(1,061,060)
290,956



Comprehensive income for the year


Loss for the year
-
-
(861,702)
(861,702)


Premium on issues
-
23,463
-
23,463


Share issued during the year
30
-
-
30


Shares cancelled during the year
(9)
-
-
(9)





At 1st January 2024
1,160
1,374,340
(1,922,762)
(547,262)



Comprehensive income for the year


Loss for the year
-
-
(1,510,452)
(1,510,452)


Premium on issues
-
24,245
-
24,245


Share issued during the year
31
-
-
31


Shares cancelled during the year
(49)
-
-
(49)



At 31st December 2024
1,142
1,398,585
(3,433,214)
(2,033,487)



The notes on pages 18 to 36 form part of these financial statements.

Page 15
 
EXAGEN GROUP LIMITED
 

CONSOLIDATED STATEMENT OF CASH FLOWS
FOR THE YEAR ENDED 31ST DECEMBER 2024

2024
2023
£
£

Cash flows from operating activities

Loss for the financial year
(5,516,435)
(4,968,947)

Adjustments for:

Amortisation of intangible assets
209,206
72,224

Depreciation of tangible assets
56,448
46,760

Loss on disposal of tangible assets
(2,274)
313

Interest paid
1,594,715
1,369,119

Interest received
(215,814)
(216,162)

Increase in work in progress
(3,838,899)
(2,975,844)

Increase in debtors
(138,797)
(147,947)

Increase in creditors
74,662
55,043

Net cash generated from operating activities

(7,777,188)
(6,765,441)


Cash flows from investing activities

Purchase of intangible fixed assets
(30,396)
(485,698)

Purchase of tangible fixed assets
(22,386)
(122,280)

Interest received
215,814
216,162

Net cash from investing activities

163,032
(391,816)

Cash flows from financing activities

Issue of ordinary shares
31
30

Purchase of ordinary shares
(49)
(9)

Other new loans
2,773,828
5,949,692

Interest paid
(1,594,715)
(1,369,119)

Share premium on issue of ordinary shares
24,245
23,463

Net cash used in financing activities
1,203,340
4,604,057

Net decrease in cash and cash equivalents
(6,410,816)
(2,553,200)

Cash and cash equivalents at beginning of year
7,815,244
10,368,444

Cash and cash equivalents at the end of year
1,404,428
7,815,244


Cash and cash equivalents at the end of year comprise:

Cash at bank and in hand
1,404,428
7,815,244


Page 16

 
EXAGEN GROUP LIMITED
 

CONSOLIDATED ANALYSIS OF NET DEBT
FOR THE YEAR ENDED 31ST DECEMBER 2024






At 1st January 2024
Cash flows
Loan movement
Other non-cash changes
At 31st December 2024
£

£

£

£

£

Cash at bank and in hand

7,815,244

(6,145,555)

-

(265,264)

1,404,425

Debt due after 1 year

(21,848,464)

-

(2,773,823)

-

(24,622,287)

Debt due within 1 year

-

-

-

-

-


(14,033,220)
(6,145,555)
(2,773,823)
(265,264)
(23,217,862)

The notes on pages 18 to 36 form part of these financial statements.

Page 17

 
EXAGEN GROUP LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31ST DECEMBER 2024

1.


General information

The principal activity of Exagen Group Limited ("the Company") is that of a holding company.
The Company is a private company limited by shares and is incorporated in England and Wales.
The principal activity of the Group is that of developing solar and battery projects.
The registered office is 2nd Floor, Coachworks, 9-10 Charlotte Mews, London, 
Greater London, England, W1T 4EF.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.

The preparation of financial statements in compliance with FRS 102 requires the use of certain critical accounting estimates. It also requires Group management to exercise judgement in applying the Group's accounting policies (see note 3).

The Company has taken advantage of the exemption allowed under section 408 of the Companies Act 2006 and has not presented its own Statement of Comprehensive Income in these financial statements.

The following principal accounting policies have been applied:

 
2.2

Basis of consolidation

The consolidated financial statements present the results of the Company and its own subsidiaries ("the Group") as if they form a single entity. Intercompany transactions and balances between group companies are therefore eliminated in full.
The consolidated financial statements incorporate the results of business combinations using the purchase method. In the Statement of Financial Position, the acquiree's identifiable assets, liabilities and contingent liabilities are initially recognised at their fair values at the acquisition date. The results of acquired operations are included in the Consolidated Statement of Comprehensive Income from the date on which control is obtained. They are deconsolidated from the date control ceases.

Page 18

 
EXAGEN GROUP LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31ST DECEMBER 2024

2.Accounting policies (continued)

 
2.3

Going concern

The financial statements have been prepared on the going concern basis which assumes that the
Group will continue to trade for the foreseeable future, being a period of at least twelve months from
the date of approval of these financial statements, and will be able to meet its debts as they fall due.
The Group made a loss for the year ended 31 December 2024 of £5,516,435 
(2023 - £4,968,947) and as at 31 December 2024, it had net liabilities of £13,616,357 (2023 - £8,124,149).
During the year certain existing shareholders provided substantial additional funding through
development loans. The directors are confident that this support will continue for at least 12 months
from the date of signature of these accounts and, in conjunction with ongoing cash generated,
believe that this will be sufficient to cover all ongoing costs.
The Company's finance function performs regular reviews and forecasts of cash flow, working capital and funding requirements, and adopts a prudent, transparent approach to budgeting and planning in order to ensure sufficient capital to meet commitments. After making enquires, reviewing forecasts in excess of the next 12 months, and taking into consideration the fact that existing shareholders have indicated their willingness to support the group, the Directors have expectation that the Company has adequate resources to continue in operational existence for the foreseeable future and that it is appropriate to continue to use the going concern basis for the preparation of these financial statements.

 
2.4

Operating leases: the Group as lessee

Rentals paid under operating leases are charged to profit or loss on a straight-line basis over the lease term.

Benefits received and receivable as an incentive to sign an operating lease are recognised on a straight-line basis over the lease term, unless another systematic basis is representative of the time pattern of the lessee's benefit from the use of the leased asset.

Page 19

 
EXAGEN GROUP LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31ST DECEMBER 2024

2.Accounting policies (continued)

 
2.5

Research and development

Research costs are recognised as an expense in profit or loss when they are incurred as research
does not directly lead to future economic benefits for the company.
Development costs are recognised as an expense in profit or loss when they are incurred.
Development costs are recognised as an intangible asset if the following criteria are met:
• There is a clearly defined project;
• Expenditure is separately identifiable;
• The project is commercially viable;
• The project is technically feasible;
• Project income is expected to outweigh cost;
• Resources are available to complete the project.

 
2.6

Interest income

Interest income is recognised in the Statement of Comprehensive Income using the effective interest method.

 
2.7

Finance costs

Finance costs are charged to the Statement of Comprehensive Income over the term of the debt using the effective interest method so that the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.

 
2.8

Borrowing costs

All borrowing costs are recognised in profit or loss in the year in which they are incurred.

 
2.9

Pensions

Defined contribution pension plan

The Group operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the Group pays fixed contributions into a separate entity. Once the contributions have been paid the Group has no further payment obligations.

The contributions are recognised as an expense in the Statement of Comprehensive Income when they fall due. Amounts not paid are shown in accruals as a liability in the Statement of Financial Position. The assets of the plan are held separately from the Group in independently administered funds.

Page 20

 
EXAGEN GROUP LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31ST DECEMBER 2024

2.Accounting policies (continued)

 
2.10

Taxation

Tax is recognised in the Statement of Comprehensive Income except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the Company and the Group operate and generate income.


 
2.11

Intangible assets

Intangible assets are initially recognised at cost. After recognition, under the cost model, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

All intangible assets are considered to have a finite useful life. If a reliable estimate of the useful life cannot be made, the useful life shall not exceed ten years.

Exagen reviews the useful lives of intangible assets on an annual basis. During the current year, management has reassessed the useful life of a specific intangible asset, previously estimated at 10 years, and determined that this estimate was no longer appropriate. It is now expected that the asset will be fully obsolete by 31 December 2027, at which point its carrying amount should be £Nil.
Accordingly, the accounting policy has been revised to reflect a straight-line amortisation over the remaining four year period. This change in estimate has been accounted for prospectively in accordance with FRS 102, with the revised amortisation charge recognised in the statement of comprehensive income.

 
2.12

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Page 21

 
EXAGEN GROUP LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31ST DECEMBER 2024

2.Accounting policies (continued)


2.12
Tangible fixed assets (continued)

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, on a reducing balance basis.

Depreciation is provided on the following basis:

Fixtures and fittings
-
33%
per annum under the reducing balance method
Office equipment
-
33%
per annum under the reducing balance method
Computer equipment
-
33%
per annum under the reducing balance method
Furniture
-
33%
per annum under the reducing balance method

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in the Statement of Comprehensive Income.

Page 22

 
EXAGEN GROUP LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31ST DECEMBER 2024

2.Accounting policies (continued)

 
2.13

Valuation of investments

Investments in subsidiaries are measured at cost less accumulated impairment.

 
2.14

Work in progress

Work in progress is stated at the lower of cost and net realisable value, being the estimated selling
price less costs to complete and sell. Cost is based on the cost of purchase. Work in progress
includes labour and attributable overheads.
At each reporting date, work in progress is assessed for impairment. If work in progress is impaired,
the carrying amount is reduced to its selling price less costs to complete and sell. The impairment
loss is recognised immediately in the Statement of Comprehensive Income.

These costs have been treated differently in the individual subsidiary companies, as the intended use differs at subsidiary level from group level. In the financial statements of the subsidiary companies theses costs are shown as tangible fixed assets since the assets will be held on a long term basis. In the Group financial statements these costs are included within work in progress since the long term plan is to sell or transfer the projects within the subsidiaries once they are fully developed.

 
2.15

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours.

In the Consolidated Statement of Cash Flows, cash and cash equivalents are shown net of bank overdrafts that are repayable on demand and form an integral part of the Group's cash management.

Page 23

 
EXAGEN GROUP LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31ST DECEMBER 2024

2.Accounting policies (continued)

 
2.16

Financial instruments

The Group only enters into basic financial instrument transactions that result in the recognition of
financial assets and liabilities like trade and other debtors and creditors, loans from banks and other
third parties, loans to related parties and investments in ordinary shares.
 
Basic financial assets

Basic financial assets, which include trade and other debtors, cash and bank balances, are initially measured at their transaction price (adjusted for transaction costs except in the initial measurement of financial assets that are subsequently measured at fair value through the Statement of Comprehensive Income) and are subsequently carried at their amortised cost using the effective interest method, less any provision for impairment, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.



Impairment of financial assets

At the end of each reporting period financial assets measured at amortised cost are assessed for objective evidence of impairment. If an asset is impaired the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset’s original effective interest rate. The impairment loss is recognised in the Statement of Comprehensive Income. 

Financial assets are impaired when events, subsequent to their initial recognition, indicate the estimated future cash flows derived from the financial asset(s) have been adversely impacted. The impairment loss will be the difference between the current carrying amount and the present value of the future cash flows at the asset(s) original effective interest rate.

If there is a favourable change in relation to the events surrounding the impairment loss then the impairment can be reviewed for possible reversal. The reversal will not cause the current carrying amount to exceed the original carrying amount had the impairment not been recognised. The impairment reversal is recognised in the Statement of Comprehensive Income.

Financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Group after the deduction of all its liabilities.

Basic financial liabilities, which include trade and other creditors, bank loans, other loans and loans due to fellow group companies are initially measured at their transaction price (adjusting for transaction costs except in the initial measurement of financial liabilities that are subsequently measured at fair value through the Statement of Comprehensive Income). When this constitutes a financing transaction, whereby the debt instrument is measured at the present value of the future payments discounted at a market rate of interest, discounting is omitted where the effect of discounting is immaterial.

Debt instruments are subsequently carried at their amortised cost using the effective interest rate method.

Page 24

 
EXAGEN GROUP LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31ST DECEMBER 2024

2.Accounting policies (continued)


2.16
Financial instruments (continued)

Trade creditors are obligations to pay for goods and services that have been acquired in the ordinary course of business from suppliers. Trade creditors are classified as current liabilities if the payment is due within one year. If not, they represent non-current liabilities. Trade creditors are initially recognised at their transaction price and subsequently are measured at amortised cost using the effective interest method. Discounting is omitted where the effect of discounting is immaterial.




3.


Judgements in applying accounting policies and key sources of estimation uncertainty

In the application of the Group's accounting policies, the directors are required to make judgements,
estimates and assumptions about the carrying amounts of assets and liabilities that are not readily
apparent from other sources. The estimates and associated assumptions are based on historical
experience and other factors that are considered to be relevant. Actual results may differ from these
estimates.
The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting
estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.
The following judgements which also include estimates have been made in applying the above accounting policies:
(a) Useful economic lives of intangible assets
The annual amortisation charge for intangible assets is sensitive to changes in the estimated useful
economic lives. The useful economic lives are reassessed annually. They are amended when necessary
to reflect current estimates, based on technological advancement, future investments, economic utilisation and the physical condition of the assets.
(b) Useful economic lives of tangible assets
The annual depreciation charge for tangible assets is sensitive to changes in the estimated useful
economic lives and residual values of the assets. The useful economic lives and residual values are
reassessed annually. They are amended when necessary to reflect current estimates, based on
technological advancement, future investments, economic utilisation and the physical condition of the
assets.
(c) Work in progress
The Group develops renewable energy generation and energy storage projects and is subject to changing cost prices. As a result it is necessary to consider the recoverability of the cost of the work in progress and the associated provisioning required.

Page 25

 
EXAGEN GROUP LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31ST DECEMBER 2024

4.


Operating loss

The operating loss is stated after charging:

2024
2023
£
£




Rent
153,367
150,283

Depreciation
56,449
46,761

Amortisation
209,206
72,224

(Profit)/Loss on sale of tangible assets
(2,274)
312





5.


Auditors' remuneration

2024
2023
£
£

Fees payable to the Company's auditors for the audit of the consolidated
and parent Company's financial statements
22,500
30,000


6.


Employees

Group
Group
Company
Company
2024
2023
2024
2023
£
£
£
£

Wages and salaries
2,351,425
1,695,585
911,680
516,935

Social security costs
268,066
209,809
107,867
66,493

Cost of defined contribution scheme
72,322
46,561
18,756
5,625

2,691,813
1,951,955
1,038,303
589,053


The average monthly number of employees, including the directors, during the year was as follows:



Group
Group
Company
Company
        2024
        2023
        2024
        2023
            No.
            No.
            No.
            No.









Directors
4
4
4
4



Employees
22
23
4
4

26
27
8
8

Page 26

 
EXAGEN GROUP LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31ST DECEMBER 2024

7.


Directors' remuneration

2024
2023
£
£




Directors' emoluments
817,208
648,198





During the year retirement benefits were accruing to 2 directors (2023 - 2) in respect of defined contribution pension schemes.

The highest paid director received remuneration of £297,058 (2023 - £250,250).

The value of the Group's contributions paid to a defined contribution pension scheme in respect of the highest paid director amounted to £NIL (2023 - £NIL).


8.


Interest receivable

2024
2023
£
£



Bank and other interest receivable
215,814
216,162


9.


Interest payable and similar expenses

2024
2023
£
£




Interest payable
1,594,715
1,369,119


10.


Taxation


2024
2023
£
£

Corporation tax


R&D tax credit
(145,908)
(142,293)


Page 27

 
EXAGEN GROUP LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31ST DECEMBER 2024
 
10.Taxation (continued)


Factors affecting tax charge for the year

The tax assessed for the year is higher than (2023 - higher than) the standard rate of corporation tax in the UK of 25% (2023 - 23.5   %). The differences are explained below:

2024
2023
£
£


Loss on ordinary activities before tax
(5,662,343)
(5,111,240)


Loss on ordinary activities multiplied by standard rate of corporation tax in the UK of 25% (2023 - 23.5   %)
(1,415,586)
(1,201,141)

Effects of:


Expenses not deductible for tax purposes, other than goodwill amortisation and impairment
-
2,689

Capital allowances for year in excess of depreciation
50,690
(397)

Increase or decrease in pension fund prepayment leading to an increase (decrease) in tax
1,819
-

Adjustment in research and development tax credit leading to an increase (decrease) in the tax charge
-
33,467

Unrelieved tax losses carried forward
1,363,828
1,017,516

Non-trading loan relationships
(183)
-

Other adjustments not otherwise stated
(568)
5,573

Research and development tax credits
(145,908)
-

Total tax charge for the year
(145,908)
(142,293)


Factors that may affect future tax charges

The company has total losses of £21.4m (2023: £12.1m) that can be offset against future taxable profits of the same nature.
A deferred tax asset has not been recognised due to the uncertainty of future profits.

Page 28

 
EXAGEN GROUP LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31ST DECEMBER 2024

11.


Intangible assets

Group and Company





Software Development

£



Cost


At 1 January 2024
878,651


Additions
30,396



At 31st December 2024

909,047



Amortisation


At 1 January 2024
72,224


Charge for the year on owned assets
209,206



At 31st December 2024

281,430



Net book value



At 31st December 2024
627,617



At 31st December 2023
806,427



Page 29

 
EXAGEN GROUP LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31ST DECEMBER 2024

12.


Tangible fixed assets

Group






Fixtures and fittings
Office equipment
Computer equipment
Furniture
Total

£
£
£
£
£



Cost or valuation


At 1 January 2024
-
27,432
198,350
-
225,782


Additions
439
1,977
35,724
125
38,265


Disposals
-
(31)
(37,653)
(1,887)
(39,571)


Transfers between classes
18,045
(26,119)
-
8,074
-



At 31st December 2024

18,484
3,259
196,421
6,312
224,476



Depreciation


At 1 January 2024
-
5,866
70,941
-
76,807


Charge for the year
4,836
458
49,176
1,978
56,448


Disposals
-
(21)
(24,648)
(1,296)
(25,965)


Transfers between classes
3,591
(5,722)
-
2,131
-



At 31st December 2024

8,427
581
95,469
2,813
107,290



Net book value



At 31st December 2024
10,057
2,678
100,952
3,499
117,186



At 31st December 2023
-
21,565
127,410
-
148,975


13.


Fixed asset investments

Company





Investments in subsidiary companies

£



Cost or valuation


At 1 January 2024
302



At 31st December 2024
302




Page 30

 
EXAGEN GROUP LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31ST DECEMBER 2024

Subsidiary undertakings


The following were subsidiary undertakings of the Company:

Name

Registered office

Principal activity

Class of shares

Holding

Exagen Development Limited
2nd Floor, Coachworks,   9-10 Charlotte Mews, London, W1T 4EF
Development of solar and battery projects
Ordinary
100%
Exagen Capital Limited
2nd Floor, Coachworks,   9-10 Charlotte Mews, London, W1T 4EF
Holding company
Ordinary
100%
Exagen Operations Limited
2nd Floor, Coachworks,   9-10 Charlotte Mews, London, W1T 4EF
Construction and asset management
Ordinary
100%
Exagen SPV HoldCo Limited
2nd Floor, Coachworks,   9-10 Charlotte Mews, London, W1T 4EF
Holding company
Ordinary
100%
Exagen Old Wood Limited
2nd Floor, Coachworks,   9-10 Charlotte Mews, London, W1T 4EF
Production of electricity
Ordinary
100%
Exagen Wymeswold Limited
2nd Floor, Coachworks,   9-10 Charlotte Mews, London, W1T 4EF
Production of electricity
Ordinary
100%
Exagen Holly Lane Limited
2nd Floor, Coachworks,   9-10 Charlotte Mews, London, W1T 4EF
Production of electricity
Ordinary
100%
Exagen Highfield Limited
2nd Floor, Coachworks,   9-10 Charlotte Mews, London, W1T 4EF
Production of electricity
Ordinary
100%
Exagen SPV01 Limited
2nd Floor, Coachworks,   9-10 Charlotte Mews, London, W1T 4EF
Dormant
Ordinary
100%
Exagen Normanton Energy Reserve Limited
2nd Floor, Coachworks,   9-10 Charlotte Mews, London, W1T 4EF
Production of electricity
Ordinary
100%
Exagen Greenhead Limited
2nd Floor, Coachworks,   9-10 Charlotte Mews, London, W1T 4EF
Production of electricity
Ordinary
100%
Exagen Brockworth Road Limited
2nd Floor, Coachworks,   9-10 Charlotte Mews, London, W1T 4EF
Production of electricity
Ordinary
100%
Exagen Services Limited
2nd Floor, Coachworks,   9-10 Charlotte Mews, London, W1T 4EF
Dormant
Ordinary
100%
Exagen Property Holdings Limited
2nd Floor, Coachworks,   9-10 Charlotte Mews, London, W1T 4EF
Dormant
Ordinary
100%
Exagen Normanton Land Limited
2nd Floor, Coachworks,   9-10 Charlotte Mews, London, W1T 4EF
Holding an option over land
Ordinary
100%
Exagen Swallett Limited
2nd Floor, Coachworks,   9-10 Charlotte Mews, London, W1T 4EF
Production of electricity
Ordinary
100%
Page 31

 
EXAGEN GROUP LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31ST DECEMBER 2024
Subsidiary undertakings (continued)


Name

Registered office

Principal activity

Class of shares

Holding

Exagen Willowfields Limited
2nd Floor, Coachworks,   9-10 Charlotte Mews, London, W1T 4EF
Production of electricity
Ordinary
100%
Exagen Oak Valley Limited
2nd Floor, Coachworks,   9-10 Charlotte Mews, London, W1T 4EF
Dormant
Ordinary
100%
Exagen SPV13 Limited
2nd Floor, Coachworks,   9-10 Charlotte Mews, London, W1T 4EF
Dormant
Ordinary
100%
Exagen SPV14 Limited
2nd Floor, Coachworks,   9-10 Charlotte Mews, London, W1T 4EF
Dormant
Ordinary
100%
Exagen Thurcroft Interchange Limited
2nd Floor, Coachworks,   9-10 Charlotte Mews, London, W1T 4EF
Production of electricity
Ordinary
100%
Exagen Beechtree Junction Limited
2nd Floor, Coachworks,   9-10 Charlotte Mews, London, W1T 4EF
Production of electricity
Ordinary
100%
Exagen Warren Wood Limited
2nd Floor, Coachworks,   9-10 Charlotte Mews, London, W1T 4EF
Production of electricity
Ordinary
100%
Exagen SPV18 Limited
2nd Floor, Coachworks,   9-10 Charlotte Mews, London, W1T 4EF
Dormant
Ordinary
100%
Exagen SPV19 Limited
2nd Floor, Coachworks,   9-10 Charlotte Mews, London, W1T 4EF
Dormant
Ordinary
100%
Exagen SPV20 Limited
2nd Floor, Coachworks,   9-10 Charlotte Mews, London, W1T 4EF
Dormant
Ordinary
100%
Exagen SPV21 Limited
2nd Floor, Coachworks,   9-10 Charlotte Mews, London, W1T 4EF
Dormant
Ordinary
100%
Exagen SPV22 Limited
2nd Floor, Coachworks,   9-10 Charlotte Mews, London, W1T 4EF
Dormant
Ordinary
100%
Exagen SPV23 Limited
2nd Floor, Coachworks,   9-10 Charlotte Mews, London, W1T 4EF
Dormant
Ordinary
100%
Exagen SPV24 Limited
2nd Floor, Coachworks,   9-10 Charlotte Mews, London, W1T 4EF
Dormant
Ordinary
100%
Exagen SPV25 Limited
2nd Floor, Coachworks,   9-10 Charlotte Mews, London, W1T 4EF
Dormant
Ordinary
100%
Exagen SPV26 Limited
2nd Floor, Coachworks,   9-10 Charlotte Mews, London, W1T 4EF
Dormant
Ordinary
100%
Exagen SPV27 Limited
2nd Floor, Coachworks,   9-10 Charlotte Mews, London, W1T 4EF
Dormant
Ordinary
100%
Page 32

 
EXAGEN GROUP LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31ST DECEMBER 2024
Subsidiary undertakings (continued)


Name

Registered office

Principal activity

Class of shares

Holding

Exagen SPV28 Limited
2nd Floor, Coachworks,   9-10 Charlotte Mews, London, W1T 4EF
Dormant
Ordinary
100%
Exagen SPV29 Limited
2nd Floor, Coachworks,   9-10 Charlotte Mews, London, W1T 4EF
Dormant
Ordinary
100%
Exagen SPV30 Limited
2nd Floor, Coachworks,   9-10 Charlotte Mews, London, W1T 4EF
Dormant
Ordinary
100%


14.


Work in progress

Group
Group
2024
2023
£
£


Work in progress
9,011,317
5,172,418


Page 33

 
EXAGEN GROUP LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31ST DECEMBER 2024

15.


Debtors

Group
Group
Company
Company
2024
2023
2024
2023
£
£
£
£

Due after more than one year

Deposits
-
40,750
-
-


Group
Group
Company
Company
2024
2023
2024
2023
£
£
£
£

Due within one year

Amounts owed by group undertakings
-
-
15,868,501
9,567,150

Other debtors
368,052
118,460
24,245
-

Called up share capital not paid
44
14
44
14

Prepayments and accrued income
108,006
178,078
-
-

476,102
296,552
15,892,790
9,567,164


Amounts owed by group undertakings includes a balance of £1.54m (2023 - £1.36m) that represents the cascading of an external loan down through the group, upon which interest is accrued at 7%. The loan is unsecured and repayable upon demand.


16.


Creditors: Amounts falling due within one year

Group
Group
Company
Company
2024
2023
2024
2023
£
£
£
£

Trade creditors
324,734
150,947
-
-

Amounts owed to group companies
-
-
9,732,307
9,732,305

Other taxation and social security
167,337
258,075
-
-

Other creditors
15,875
10,266
8
7

Accruals and deferred income
122,767
136,763
23,250
33,750

630,713
556,051
9,755,565
9,766,062


Page 34

 
EXAGEN GROUP LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31ST DECEMBER 2024

17.


Creditors: Amounts falling due after more than one year

Group
Group
Company
Company
2024
2023
2024
2023
£
£
£
£

Loans
24,622,287
21,848,464
9,184,215
7,451,172


The loans are unsecured, accrued interest at a rate of 7% and repayable within 1 to 6 years.


18.


Share capital

2024
2023
£
£
Allotted, called up and fully paid



1,058,600 (2023 - 1,058,600) Ordinary A shares of £0.001 each
1,058.60
1,058.60
45,600 (2023 - 68,000) Ordinary B shares of £0.001 each
45.60
68.00
38,600 (2023 - 34,000) Ordinary C shares of £0.001 each
38.60
34.00

1,142.80

1,160.60

22,400 Ordinary B share have been cancelled and repurchased at the nominal value.
31,000 Ordinary C shares of £0.001 each were issued in 2024 for a total cash consideration of £31, in terms of a share plan under which directors and employees of the Company have the opportunity to subscribe for shares in the Company. During the year 26,400 Ordinary C shares were also cancelled and repurchased at the nominal value in respect of the aformentioned share plan.



19.


Reserves

Share premium account

The company allotted 15,000 Ordinary C shares of £0.001 per share at a premium of £0.7821 per share,
for cash, on 3 June 2024.
The company allotted 4,000 Ordinary C shares of £0.001 per share at a premium of £0.7821 per share,
for cash, on 18 June 2024.
The company allotted 16,000 Ordinary C shares of £0.001 per share at a premium of £0.7821 per share,
for cash, on 14 September 2024.
The company allotted 2,000 Ordinary C shares of £0.001 per share at a premium of £0.7821 per share,
for cash, on 12 November 2024.

Page 35

 
EXAGEN GROUP LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31ST DECEMBER 2024

20.


Pension commitments

The Group operates a defined contributions pension scheme. The assets of the scheme are held separately from those of the Group in an independently administered fund. The pension cost charge represents contributions payable by the Group  to the fund and amounted to £72,322 (2023 - £46,561). Contributions totalling £15,480 (2023 - £18,029) were payable to the fund at the reporting date and are included in creditors.


21.


Commitments under operating leases

At 31st December 2024 the Group and the Company had future minimum lease payments due under non-cancellable operating leases for each of the following periods:


Group
Group
2024
2023
£
£

Not later than 1 year
124,275
160,000

Later than 1 year and not later than 5 years
279,424
-

403,699
160,000

22.


Related party transactions

Where possible the Company and Group has taken advantage of the exemption conferred by FRS 102
section 33.1A from the requirement to disclose transactions with other wholly owned group undertakings
on the grounds that consolidated financial statements are prepared by the parent undertaking and are
publicly available.
Included within trade creditors is a balance of £NIL owed to a director 
(2023: £1,247).
Included within trade creditors is a balance of £NIL owed to a related party 
(2023: £1,020).
Included within other debtors is a balance of £3,023 
(2023: £18,198) owed from a company with whom a resigned director was connected. This was received post year end.
Included within administrative expenses are £NIL 
(2023: £69,000) of legal and professional fees incurred by a company under common control.


23.


Controlling party

The controlling party is OEDP UK HoldCo Ltd ["OEDP"] (2023 - J Littman)
On 23rd September 2024, OEDP, a minority shareholder, acquired all Ordinary
A shares in the Group. As a result of this transaction, OEDP has become the Group’s controlling party.

Page 36